InterCept Inc Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (46)

Latest Posts

About This Stock More About This Stock
Abbvie Earnings Drive Biotech Stocks Higher With Large Caps Dominant
Article By: Rod Raynovich
Friday, January 26, 2018 6:44 PM EDT
Biotech stocks soared again today to new highs driven by Abbvie Inc. earnings and overall sector strength. Momentum was strong in the general market with NASDAQ up 1.28% and the S&P up 1.18%. The M&A theme should be the driver in 2017.
In this article: IBB, REGN, BIIB, NBIX, XBI, ICPT, ESPR, ABBV, PTLA
Read
Oppenheimer Downgrades Intercept Despite Two-Day Share Collapse
Article By: The Fly
Friday, September 22, 2017 2:23 PM EDT
Oppenheimer analyst Jay Olson downgraded this afternoon shares of Intercept Pharmaceuticals to Perform from Outperform.
In this article: ICPT
Read
Technicals Always Don’t Work Out The Way You Would Expect
Article By: Bespoke Investment Group
Friday, September 22, 2017 11:42 AM EDT
At the most recent trading day shown, the stock broke out above resistance to a new medium-term high. Not only that, but volume on the day of the breakout was also strong, coming in at twice the 50-day moving average.
In this article: ICPT
Read
Citi Calls FDA Communication 'New Negative' For Intercept Shares
Article By: The Fly
Thursday, September 21, 2017 7:45 PM EDT
ICPT stock in afternoon trading was down 18%.
In this article: ICPT
Read
Intercept Slides As Analyst Calls CymaBay Drug 'True Contender' After Data
Article By: The Fly
Monday, July 17, 2017 3:33 PM EDT
Shares of Intercept Pharmaceuticals are sliding after H.C. Wainwright analyst Ed Arce raised his price target for its competitor CymaBay Therapeutics following data from the company's Phase 2 study of seladelpar in primary biliary cholangitis.
In this article: ICPT Also: CBAY
Read

PARTNER HEADLINES

Latest Tweets for $ICPT

No tweets yet!